ACVR2A and cancer: However, while altered gut microbiota in tumor-bearing mice was demonstrated, sACVR2B did not prevent the cancer-associated alterations in gut microbiota [224], suggesting that improved survival with ACVR2 ligand blocking is not mediated via changes in gut microbiome.